Yann Chong Tan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Yann chong tan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Yann Chong Tan Today - Breaking & Trending Today
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Nuevocor, a pre-clinical stage biotechnology company focused on developing cardiac genetic medicines through a unique platform to understand. ....
Atreca (NASDAQ:BCEL – Get Rating) and Mustang Bio (NASDAQ:MBIO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 40.2% of Atreca shares are owned […] ....
SINGAPORE, Dec. 21, 2022 /PRNewswire/ Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will also be giving an oral presentation on new pre-clinical data for its LMNA cardiac gene therapy. ....
SINGAPORE, BOSTON and SHANGHAI, June 28, 2022 /PRNewswire/ Cargene Biopharma Inc. ("Cargene", the "Company"), a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, is excited to welcome Kathy He, a seasoned biopharmaceutical industry executive, to join the Company as Chief Executive Officer and a member of the board. Kathy brings over 20 years of R&D and commercial experience from multiple global companies to her new role at Cargene, notably in building differentiated product portfolios, developing strategic opportunities, and successfully bringing innovative therapeutics to market. Based in Singapore, Boston and Shanghai, Cargene Biopharma aims to leverage its novel biology and chemistry insights to develop highly specific, stable and potent nucleic acid therapeutics for a broad range of diseases. In December 2021, the Company successfully closed a pre-Series A funding round of nearly US$20 million, led by Bio ....